While the number of clinical trials in Ukraine is increasing and their efficiency and quality as well, patient recruitment and retention becomes more crucial.
Success of the trial depends on identifying the right patients for the trial and their further engagement to invest their time and effort into drug development. Patient recruitment is considered to be one of the most difficult challenges and it is estimated that 80% of clinical trials do not meet their patient enrolment deadlines.
Besides, patients retention is also a matter of concern, considering that the approximate dropout rate across clinical studies is around 30%. While the reasons for patient dropouts can vary, in a lot of cases, dropouts can be predicted and thus prevented.